C. M.
- Country
- Ireland
- Department
- Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 138 partner sites.
Specializations
Hematologic Malignancies
Investigation of malignant disorders of the blood and bone marrow, emphasizing innovative therapeutic combinations.
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndromes (MDS)
- Chronic Lymphocytic Leukemia (CLL)
- Multiple Myeloma
- Mantle Cell Lymphoma
- Diffuse Large B‑Cell Lymphoma (DLBCL)
Focus on disease‑specific pathways and resistance mechanisms.
Targeted Lung Cancer Therapy
Clinical research on non‑small cell lung cancer subtypes driven by actionable mutations.
- Non‑Small Cell Lung Cancer (NSCLC)
- KRAS‑G12C Mutant NSCLC
- FLT3‑Mutated AML
Integration of immunotherapy with targeted inhibitors to improve survival outcomes.
Breast Cancer Precision Medicine
Exploration of hormone‑receptor and HER2‑directed strategies across early and advanced disease stages.
- Hormone Receptor‑Positive Breast Cancer
- HER2‑Positive Breast Cancer
- Triple‑Negative Breast Cancer
- High‑Risk Early Breast Cancer
Evaluation of adjuvant endocrine combinations and antibody‑drug conjugates.
Solid Tumor Oncology Beyond Breast and Lung
Broad engagement with major solid malignancies, focusing on molecular and hormonal interventions.
- Prostate Cancer
- Ovarian Cancer
- Colorectal Cancer
- Gastric Cancer
- Esophageal Cancer
Incorporation of androgen receptor blockade and anti‑angiogenic agents.
Rare and Genetic Disorders
Targeted studies addressing inherited and uncommon hematologic conditions.
- Cystic Fibrosis
- Myelodysplastic Neoplasms
- Venous Thromboembolism (VTE)
Prioritization of disease‑modifying regimens and safety assessments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.